HomeProductsBuilding BlocksHeterocyclic ScaffoldsPiperazinesOpipramol
Chemical structure of CAS 315-72-0

Opipramol

In Stock•Starting at $90 for 5 mg•Purity ≥ 98%
CAS No.315-72-0
MDL No.MFCD00865455
MFC23H29N3O
MW363.50
InChI KeyYNZFUWZUGRBMHL-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$90In Stock
10 mg98%$134In Stock
25 mg98%$222In Stock
50 mg98%$396In Stock
100 mg98%$614In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol is a dibenzoazepine.

CAS No.315-72-0
Product NameOpipramol

Associated Conditions

Dementia·Anxiety·major depressive disorder·drug dependence·depressive disorder·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Bioavailability of opipramol from a film-coated tablet, a sugar-coated tablet and an aqueous solution in healthy volunteers.

Arzneimittel-Forschung • Vol. 53, Issue 2 • 2003
PMID: 12642963DOI: 10.1055/s-0031-1297077

Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.

Phytomedicine : international journal of phytotherapy and phytopharmacology • Vol. 10 Suppl 4 • 2003
PMID: 12807341DOI: 10.1078/1433-187x-00309

Specific modulation of sigma binding sites by the anxiolytic drug opipramol.

Journal of neural transmission (Vienna, Austria : 1996) • Vol. 110, Issue 10 • 2003
PMID: 14523629DOI: 10.1007/s00702-003-0019-5

Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry.

Clinical chemistry and laboratory medicine • Vol. 41, Issue 12 • 2003
PMID: 14708881DOI: 10.1515/CCLM.2003.240

Documentation

Similar Products